Epigenetics in Precision Medicine, Volume 30

1. Perspectives and future directions of Translational Epigenetics in Personalized and Precision Medicine
   2. Translational Epigenetics in Precision medicine of colorectal cancer
   3. Epigenetics inPrecision medicine of breast cancer
   4. Epigenetics and Precision medicine in prostate cancer
   5. Epigenetics and precision medicine in lung cancer
   6. Epigenetics and precision medicine in bone and Soft Tissue sarcomas
   7. Epigenetics and precision medicine in gynecological cancer
   8. Epigenetics in precision medicine of pancreatic cancer
   9. Epigenetics and precision medicine in diabetes and obesity prevention and management
   10. Epigenetics in precision medicine of cardiovascular disease
   11. Epigenetic markers for major psychosis as targets for precision medicine
   12. Epigenetics and precision medicine in infertility and reproductive medicine
   13. Epigenetics and precision medicine in neurodegenerative Diseases
   14. Epigenetics and precision medicine in auto-immune diseases
   15. Epigenetics and precision medicine in allergic diseases
   16. Epigenetics in spine curvature disorders
   17. Epigenetics and precision medicine in infectious diseases
   18. Epigenetics and precision medicine in Rare Diseases
   19. EpiSwitch biomarkers based on chromosomal conformation signatures for personalized medicine
   20. Application of hypermethylated DNA markers for the detection of circulating tumor DNA (ctDNA) in colorectal
   

In recent years, knowledge of epigenetic mechanisms underlying disease onset and progression has proven crucial for the development of novel early diagnosis and prognosis biomarkers for patient stratification and precision medicine. Epigenetics in Precision Medicine, a new volume in the Translational Epigenetics series, provides a thorough discussion and overview of current developments in clinical epigenetics with special emphasis on epigenetic biomarkers that can be used for clinical diagnosis, prognosis, patient stratification, and treatment monitoring. Disease types discussed include cancer, metabolic disorders, neurodegenerative diseases, bone disease, and immune-related disorders. The book examines the challenges of advancing epigenetics research and translating findings to the clinic and drug discovery in each of these areas, as well as current solutions; chapter authors discuss how to leverage epigenomic technologies, applications, and tools, such as next-generation sequencing, to discover new epigenetic biomarkers in disease and drug studies.

Epigenetics in Precision Medicine focuses on complex epigenetic mechanisms in several pathologies, and explores how epigenetics can power the advance of precision medicine, not only by improving in vitro diagnostic and prognostic tools, but by providing new therapeutic approaches to treat human disease.

• Provides a thorough grounding in epigenetics-driven precision medicine, with emphasis on developing and implementing early diagnosis and prognosis biomarkers, and supporting patient stratification
• Empowers researchers and clinicians to incorporate epigenetics in new disease research, drug discovery, and clinical practice
• Features chapter contributions from international leaders in the field

Human geneticists; human genomicists; translational researchers in genomic medicine, epigenetics, biochemistry, molecular biology, oncology, neurology, endocrinology, reproductive medicine, pulmonary medicine, gerontology and anti-aging medicine, pediatrics, and bioinformatics; life science researchers; biotechnologists; developmental biologists; clinicians and graduate students in the biosciences